irblog.prnewswire.com

SIFI appoints Jelle Kleijn as Global Head of Acanthamoeba Keratitis to globally lead the effort to deliver the first registered treatment for this rare sight-threatening ...

CATANIA, Italy, Dec. 7, 2020 /PRNewswire/ -- SIFI, a leading ophthalmic company, is pleased to announce the recent appointment of Jelle Kleijn, PhD, as Global Head of Acanthamoeba Keratitis. Jelle ...
Yahoo Finance

SIFI provides updates on the UK and US regulatory pathways for AKANTIOR® in the treatment of acanthamoeba keratitis

Type C meeting feedback confirms pre-clinical and clinical data are adequate for an NDA submission and potential approval of AKANTIOR® in the US CATANIA, Italy, Dec. 16, 2024 /PRNewswire/ -- SIFI, a ...
Yahoo Finance

Spend management startup SiFi raises $10M to grow further in Saudi Arabia

The global spend management sector is experiencing a tailwind of sorts. North America is arguably the biggest market in this space, but spend management companies have seen demand rise across the ...
streetinsider

SIFI ANNOUNCES LICENSE AGREEMENT WITH AVANZANITE BIOSCIENCE FOR AKANTIOR®

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here. Collaboration offers potential access to hundreds of patients across several European Countries. SIFI will focus ...
Medindia

SIFI provides updates on the UK and US regulatory pathways for AKANTIOR® in the treatment of acanthamoeba keratitis

CATANIA, Italy, Dec. 16, 2024 /PRNewswire/ -- SIFI, a leading international ophthalmic company, announced the accomplishment of a key milestone in the pursuit of regulatory approvals in the United ...